심부전 IV: 분류 및 진단 평가

The functional classification divides heart failure into four classes based on physical activity limitations. Class I has no limitations during ordinary activities like walking. Class II includes slight limitations with symptoms during ordinary activities. Class III has marked limitations with symptoms during less-than-ordinary activities. Class IV presents severe limitations with symptoms even at rest.

Stage A identifies patients at high risk for developing heart failure without structural heart disease or symptoms, focusing on treating risk factors. Stage B signifies structural heart disease without symptoms, such as previous myocardial infarction or reduced ejection fraction. Treatment in Stage B includes beta-blockers or ACE inhibitors to slow disease progression.

Class III patients are comfortable at rest but experience significant symptoms during less-than-ordinary activities like dressing or light housework. Class IV patients cannot perform any physical activity without discomfort and experience symptoms even at rest, including severe fatigue, palpitations, shortness of breath, and potentially chest pain.

Stage C involves patients with structural heart disease and current or past symptoms of heart failure. Management focuses on relieving symptoms, improving quality of life, and preventing hospitalizations through a combination of medications, lifestyle changes, and possibly device therapy such as implantable cardioverter-defibrillators or cardiac resynchronization therapy.

Stage D represents advanced heart failure with severe symptoms refractory to conventional treatment. Management includes specialized interventions such as mechanical circulatory support, heart transplantation, or palliative care to improve quality of life, rather than standard medications and lifestyle modifications used in earlier stages.

The functional classification based on physical activity limitations helps assess symptom burden and daily functioning. The disease progression and severity classification stages patients based on structural heart disease presence and treatment strategies, providing a comprehensive framework for diagnosis and management planning across the disease continuum.

Stage A identifies patients at high risk for developing heart failure without structural disease or symptoms. Risk factors include hypertension, diabetes, obesity, metabolic syndrome, or a family history of cardiomyopathy. Management focuses on lifestyle modification and treatment of underlying conditions to prevent heart failure development.